Lionbridge’s Integrated Global Regulatory Solutions Simplify, Accelerate and Support Organizations’ Multinational Compliance.
NATIONAL HARBOR, Md. – September 11, 2017 – Lionbridge Technologies, Inc., the world’s most trusted translation and digital communications company, will exhibit its Global Regulatory Solutions for Life Sciences this week at the 2017 Regulatory Convergence Event, presented by the Regulatory Affairs Professionals Society (RAPS). Lionbridge’s regulatory solutions help life sciences organizations meet ever-changing global regulatory requirements through a variety of specialized services ranging from translation to label creation to independent review.
As pharmaceutical and medical device companies expand distribution of medicines and products around the globe, maintaining timelines is critical to avoiding delays or upholding the scheduled release cycle. However, managing global regulatory documentation presents many challenges. Around the world, diverse regions have their own medical advisory bodies or underwriters, and many organizations struggle to adhere to these diverse compliance requirements—particularly when working against strict timelines.
“Local regulatory authorities are taking a more active role in how pharma and medical device products come to market in their regions, and many organizations are struggling to execute multilingual, transnational campaigns,” said Mark Aiello, General Manager, Lionbridge Life Sciences. “It can be complex to centralize processes and manage cultural adaptation and translation in a regulated environment. Lionbridge’s Global Regulatory Solutions for Life Sciences empower organizations with the management, tools and expertise they need to complete on-time, high-quality submissions to local regulatory bodies, and ultimately accelerate time to market.”
Lionbridge’s life sciences regulatory solutions adhere to validated certifications and rigorous methodologies to deliver high-quality regulatory translation services and strategy in one integrated solution, while focusing on fast turnaround times to help organizations comply with the ever-changing, ever-challenging global regulatory environment. Key benefits include:
Lionbridge’s robust Global Regulatory Solutions portfolio also includes the company’s recently enhanced Clinical Labeling translation solution, an end-to-end offering that helps global life sciences organizations easily translate labeling content for clinical studies, while remaining compliant with global regulatory requirements.
Attendees at the 2017 Regulatory Convergence Event can view a demo of the Global Regulatory Solutions for Life Sciences onsite at the Lionbridge booth #405.
To learn more about Lionbridge’s proven, rigorous process to support multilingual regulatory and compliance needs, visit https://www.lionbridge.com/en-us/life-sciences/global-regulatory-solutions.